Key Points

COVID-19

• Decrease in the incidence rate (-25%) and decrease in the positivity rate (2.8% vs. 3.8%) compared to Week 21

• Stabilization of the testing rate

• Emerging SARS-CoV-2 variants: 79.0% of cases identified as suspected 501Y.V1 (Alpha) variants and 2.8% as suspected 501Y.V2 (Beta) or 501Y.V3 (Gamma) variants. Two cases of the 21A/478K variant (B.1.617.2, Delta) identified through random sequencing

• Slight decrease in emergency room visits for suspected COVID-19, hospitalizations, and critical care admissions

• Slight decrease in SOS Médecins calls for suspected COVID-19